// App-Quantinova.ai

: Poor Outcome of CRLF2 Rearranged Philadelphia Negative Acute Lymphoblastic Leukemia Adults Patients

Researchers

Presenter

  • Yasser H Elnahass

Principal Investigators

  • Omar A Fahmy

  • Mohamed Abdel Mooti Samra

  • Fatma A Elrefaey

  • Mahmoud T Bokhary

  • Haitham Elsherif

  • Hazem H Afifi

  • Abdallah S Elkomy

  • Mona Hola

  • Hossam K Mahmoud

Medical Centers

  • National Cancer Institute, Cairo University, Cairo, Egypt

  • Faculty of Medicine, Ain Shams University, Cairo, Egypt, Cairo, Egypt

  • Cairo University, Cairo, Egypt

  • Nasser Institute of Health, Cairo, Egypt

  • Nasser Institute of Health, Cairo, Egypt

  • Cytogenetics Lab, Nasser Institute of Health, Cairo, Egypt

  • Clinical Pathology Department. National Cancer Institute, Cairo University, Cairo, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved